Toronto Dominion Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-573,820
Closed -$105M 1538
2021
Q2
$105M Buy
573,820
+216,160
+60% +$39.7M 0.16% 85
2021
Q1
$54.7M Buy
357,660
+220,392
+161% +$33.7M 0.1% 136
2020
Q4
$21.4M Sell
137,268
-252,104
-65% -$39.4M 0.04% 253
2020
Q3
$44.6M Buy
389,372
+243,792
+167% +$27.9M 0.11% 128
2020
Q2
$16.3M Sell
145,580
-22,007
-13% -$2.47M 0.04% 286
2020
Q1
$15M Sell
167,587
-39,599
-19% -$3.56M 0.05% 252
2019
Q4
$22.4M Buy
207,186
+40,497
+24% +$4.38M 0.04% 259
2019
Q3
$16.3M Sell
166,689
-151,791
-48% -$14.9M 0.03% 293
2019
Q2
$20.9M Buy
318,480
+162,731
+104% +$10.7M 0.04% 238
2019
Q1
$21M Buy
155,749
+22,041
+16% +$2.98M 0.03% 242
2018
Q4
$13M Sell
133,708
-11,589
-8% -$1.13M 0.02% 282
2018
Q3
$20.2M Sell
145,297
-3,756
-3% -$522K 0.04% 244
2018
Q2
$18.5M Buy
149,053
+29,437
+25% +$3.65M 0.04% 249
2018
Q1
$13.3M Buy
119,616
+23,394
+24% +$2.61M 0.03% 276
2017
Q4
$11.5M Buy
96,222
+11,505
+14% +$1.38M 0.03% 264
2017
Q3
$11.9M Buy
84,717
+8,646
+11% +$1.21M 0.04% 232
2017
Q2
$9.25M Buy
76,071
+15,464
+26% +$1.88M 0.03% 270
2017
Q1
$7.35M Buy
60,607
+21,938
+57% +$2.66M 0.02% 271
2016
Q4
$4.73M Buy
38,669
+32,122
+491% +$3.93M 0.01% 268
2016
Q3
$802K Buy
6,547
+5,308
+428% +$650K ﹤0.01% 352
2016
Q2
$145K Sell
1,239
-490
-28% -$57.3K ﹤0.01% 476
2016
Q1
$241K Sell
1,729
-5,178
-75% -$722K ﹤0.01% 367
2015
Q4
$1.32M Sell
6,907
-294
-4% -$56.1K 0.01% 229
2015
Q3
$1.13M Buy
7,201
+1,023
+17% +$160K 0.01% 233
2015
Q2
$1.12M Buy
6,178
+618
+11% +$112K 0.01% 256
2015
Q1
$964K Sell
5,560
-2,621
-32% -$454K ﹤0.01% 262
2014
Q4
$1.51M Buy
8,181
+4,447
+119% +$823K 0.01% 241
2014
Q3
$619K Buy
3,734
+3
+0.1% +$497 ﹤0.01% 298
2014
Q2
$583K Buy
3,731
+573
+18% +$89.5K ﹤0.01% 334
2014
Q1
$480K Buy
3,158
+29
+0.9% +$4.41K ﹤0.01% 353
2013
Q4
$416K Buy
+3,129
New +$416K ﹤0.01% 367